With its cardiac patch fully developed and FDA pre-submission filed, BioXgen is inviting investors and the public to ...

Built on tens of thousands of hours of due diligence calls and investor meetings, the free tool at 1752.ai delivers ...

Geviti launches a free, clinically backed AI platform turning complex blood biomarker data into clear, actionable health insights.